Tvardi Therapeutics Inc.
TVRD | NASDAQ
$1.69
+$0.08 (+4.97%)
Sep 22, 2026, 2:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.46M | -6.8M | -7.28M | -5.53M | -506K | -9.58M | -12.71M | -12.48M | -20.02M | -30.7M | -32.34M | -28.03M |
Depreciation & Amortization | 23K | 24K | 24K | 24K | 47K | 24K | 24K | 73K | 77K | 42K | 82K | 521K |
Stock-Based Compensation | n/a | 370K | 353K | 339K | -719K | 80K | n/a | n/a | n/a | 3.35M | 85K | n/a |
Other Working Capital | -986K | 354K | 1.23M | 914K | -460K | -3.42M | 2.53M | -2.97M | 2.38M | 4.09M | 4.67M | 1.87M |
Other Non-Cash Items | -1.81M | 197K | -15K | -7K | -10.13M | 5.45M | 2.07M | 8.98M | 5.36M | 1.74M | 4.82M | 3.23M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -986K | 354K | 1.23M | 914K | 2.45M | -3.66M | 5.78M | -10.57M | 2.14M | -4.89M | 10.07M | 4.64M |
Operating Cash Flow | -9.23M | -5.86M | -5.69M | -4.26M | -8.87M | -7.69M | -4.83M | -13.98M | -12.44M | -30.45M | -17.37M | -19.65M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -210K | -836K | -2.05M | -323K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -31.49M | -16.38M | n/a | n/a | 32.21M | -32.21M | -65M | -22.85M |
Sales Maturities Of Investments | n/a | n/a | 5M | 5.35M | 11.05M | 5.49M | n/a | 2.5M | 15.5M | 59M | 36.85M | 46.33M |
Other Investing Acitivies | 5.14M | 4.98M | n/a | n/a | n/a | n/a | n/a | n/a | -32.21M | n/a | n/a | n/a |
Investing Cash Flow | 5.14M | 4.98M | 5M | 5.35M | -20.43M | -10.88M | n/a | 2.5M | 15.29M | 25.95M | -30.21M | 23.16M |
Debt Repayment | n/a | n/a | n/a | n/a | -1.01M | n/a | 28.3M | -694K | -610K | -685K | 36.47M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | -429K | 22.6M | -1.61M | -1.29M | n/a | -5K | n/a | n/a | n/a |
Financial Cash Flow | n/a | n/a | 1K | -322K | 22.02M | -1.6M | 27.01M | -694K | -610K | -685K | 36.48M | 1.12M |
Net Cash Flow | -4.09M | -883K | -684K | 770K | -13.57M | -20.18M | -6.95M | -10.68M | 2.24M | -5.19M | -11.1M | 4.63M |
Free Cash Flow | -9.23M | -5.86M | -5.69M | -4.26M | -8.87M | -7.69M | -4.83M | -13.98M | -12.65M | -31.29M | -19.42M | -19.97M |
Adj. Free Cash Flow | -9.23M | -6.23M | -6.04M | -4.6M | -8.15M | -7.77M | -4.83M | -13.98M | -12.65M | -34.63M | -19.51M | -19.97M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -210K | -836K | -2.05M | -323K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -9.23M | -5.86M | -5.69M | -4.26M | -8.87M | -7.69M | -4.83M | -13.98M | -12.65M | -31.29M | -19.42M | -19.97M |
Add to Watchlist
Select watchlists to add or remove TVRD